KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Goodwill & Intangibles (2017 - 2025)

Novartis Ag's Goodwill & Intangibles history spans 9 years, with the latest figure at $55.0 billion for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles rose 6.4% year-over-year to $55.0 billion; the TTM value through Dec 2025 reached $55.0 billion, up 6.4%, while the annual FY2025 figure was $55.0 billion, 6.4% up from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $55.0 billion at Novartis Ag, up from $51.7 billion in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $60.9 billion in Q4 2022 and bottomed at $29.6 billion in Q4 2021.
  • The 5-year median for Goodwill & Intangibles is $51.7 billion (2024), against an average of $49.5 billion.
  • The largest annual shift saw Goodwill & Intangibles plummeted 69.43% in 2021 before it surged 105.93% in 2022.
  • A 5-year view of Goodwill & Intangibles shows it stood at $29.6 billion in 2021, then soared by 105.93% to $60.9 billion in 2022, then decreased by 17.6% to $50.2 billion in 2023, then increased by 2.89% to $51.7 billion in 2024, then rose by 6.4% to $55.0 billion in 2025.
  • Per Business Quant, the three most recent readings for NVS's Goodwill & Intangibles are $55.0 billion (Q4 2025), $51.7 billion (Q4 2024), and $50.2 billion (Q4 2023).